2 results
Approved WMORecruiting
The objective of the study is to evaluate the efficacy and safety of a single dose of fosaprepitant when administered concomitantly with ondansetron, with or without dexamethasone, in subjects birth to 17 years of age receiving emetogenic…
Approved WMOWill not start
Primary Objective: The primary objective of this randomized controlled study is to assess the safety and efficacy of the VITARIA* System when added to stable, guideline-directed medical therapy for patients with heart failure and reduced left…